Watchdog | Authorisation list (Annex XIV)

Source:	https://echa.europa.eu/authorisation-list
Items:	141
About list:	List of substances to be eventually removed from the market. More about this list and ECHA SVHC.

Authorisation list (Annex XIV)

1,2,5,6,9,10-hexabromocyclododecane

Scope: PBT (Article 57d)

Authorisation list (Annex XIV)

1,2-Benzenedicarboxylic acid, di-C6-10-alkyl esters

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-benzenedicarboxylic acid, di-C6-10-alkyl esters or mixed decyl and hexyl and octyl diesters

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7-rich

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-Benzenedicarboxylic acid, dipentyl ester, branched and linear

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

1,2-dichloroethane (EDC)

Scope: Carcinogenic (Article 57a)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

14-(nonylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

17-(4-nonylphenoxy)-3,6,9,12,15-pentaoxaheptadecan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

1-bromopropane (n-propyl bromide)

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

20-(4-nonylphenoxy)-3,6,9,12,15,18-hexaoxaicosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

20-(isononylphenoxy)-3,6,9,12,15,18-hexaoxaicosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

20-(nonylphenoxy)-3,6,9,12,15,18-hexaoxaicosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-{2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-{2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethoxy}ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-[2-(4-nonylphenoxy)ethoxy]ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2,2'-dichloro-4,4'-methylenedianiline (MOCA)

Scope: Carcinogenic (Article 57a)

Authorisation list (Annex XIV)

2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328)

Scope: PBT (Article 57d), vPvB (Article 57e)

Authorisation list (Annex XIV)

2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol (UV-350)

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

2-[2-(nonylphenoxy)ethoxy]ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

23-(nonylphenoxy)-3,6,9,12,15,18,21-heptaoxatricosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2,4-dinitrotoluene (2,4-DNT)

Scope: Carcinogenic (Article 57a)

Authorisation list (Annex XIV)

2,4-di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol (UV-327)

Scope: vPvB (Article 57e)

Authorisation list (Annex XIV)

2-(4-nonylphenoxy)ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

26-(4-Nonylphenoxy)-3,6,9,12,15,18,21,24- octaoxahexacosan -1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV-320)

Scope: PBT (Article 57d), vPvB (Article 57e)

Authorisation list (Annex XIV)

2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

Scope: Toxic for reproduction (Article 57c)

Authorisation list (Annex XIV)

2-(isononylphenoxy)ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)

Authorisation list (Annex XIV)

2-(nonylphenoxy)ethanol

Scope: Endocrine disrupting properties (Article 57(f) - environment)